Wabtec (WAB)
NYSEIndustrialsRailroadsSnapshot 2026-09-04
NYSEIndustrialsRailroadsSnapshot 2026-09-04
QuarterlyIQ Insights · WAB
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $283 the market pays 29× p/e — above the 21× p/e peer median but in line with its own 29× history. That premium reflects a durable franchise our peer-anchored $280 fair value understates; treat the 'expensive vs peers' read with medium confidence. Analysts target $330–$355. Note: our $280 fair value sits below the entire analyst range ($330–$355). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $340.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $749.95 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $433.80 | — | — | Hist. CAGR | high |
| graham number | 12M | $121.46 | — | — | TTM | high |
| Peer EV/EBITDA |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$330.00 – $355.00 (median $340.00) · 4 analysts · as of 2026-07-23
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 111% over what the business is worth with no growth; closing that gap needs roughly 17.6 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $8.18/sh owner earnings.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| 12M |
| $201.08 |
| 15.4 |
| 15.37 |
| TTM |
| high |
| Peer P/FCF | 12M | $213.37 | 21.5 | 9.94 | TTM | high |
| Peer P/E | 12M | $211.59 | 21.4 | 9.89 | TTM | high |
| Peer P/S | 12M | $73.24 | 1.0 | 70.64 | TTM | high |
| PEG | 12M | $224.66 | 22.7 | 9.89 | TTM | high |
| residual income | 12M | $80.11 | — | — | TTM | high |
| Own P/E history | 12M | $290.68 | 29.4 | 9.89 | TTM | high |
| triangulated | 12M | $215.52 | 21.4 | 10.07 | Triangulated | high |
| Peer P/FCF | 3Y | $324.51 | 21.5 | 15.12 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $284.74 | 21.4 | 13.31 | Analyst | medium |
| Peer P/S | 3Y | $87.83 | 1.0 | 84.70 | guidance | medium |
| PEG | 3Y | $302.32 | 22.7 | 13.31 | Analyst | medium |
| Own P/E history | 3Y | $391.17 | 29.4 | 13.31 | Analyst | medium |
| Peer P/FCF | 5Y | $429.16 | 21.5 | 20.00 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $307.52 | 21.4 | 14.37 | Analyst | high |
| Peer P/S | 5Y | $94.86 | 1.0 | 91.48 | guidance | high |
| PEG | 5Y | $326.51 | 22.7 | 14.37 | Analyst | high |
| Own P/E history | 5Y | $422.47 | 29.4 | 14.37 | Analyst | high |